Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$372.36 - $412.07 $114,314 - $126,505
-307 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$357.26 - $392.57 $109,678 - $120,518
307 New
307 $118,000
Q2 2020

Aug 14, 2020

SELL
$270.93 - $320.3 $344,622 - $407,421
-1,272 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$243.44 - $359.98 $309,655 - $457,894
1,272 New
1,272 $351,000
Q2 2018

Aug 13, 2018

SELL
$217.98 - $237.23 $33,786 - $36,770
-155 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$218.74 - $251.43 $316,079 - $363,316
-1,445 Reduced 90.31%
155 $35,000
Q4 2017

Feb 02, 2018

SELL
$217.88 - $244.43 $31,592 - $35,442
-145 Reduced 8.31%
1,600 $349,000
Q3 2017

Nov 13, 2017

SELL
$231.6 - $253.39 $4.36 Million - $4.77 Million
-18,815 Reduced 91.51%
1,745 $414,000
Q2 2017

Aug 14, 2017

BUY
N/A
20,560
20,560 $4.92 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.